ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Total en bloc spondylectomy with artificial vertebral body replacement for thoracic spinal hydatidosis with hepatic involvement: a case report and literature review.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo report a rare case of thoracic spinal hydatid disease with concomitant hepatic involvement successfully treated by total en bloc spondylectomy (TES) and vertebral body reconstruction. This report focuses on the surgical decision-making process for a neurologically intact patient with extensive disease and provides a detailed technical description of the procedure, including the use of a single-stage, posterior-only approach. CASE PRESENTATION: A 63-year-old female with a history of sheep farming presented with a 20-day history of low back pain. Imaging revealed a destructive lesion at T12 with paravertebral extension and a complex cystic lesion in the right hepatic lobe. Serology was positive for hydatid IgG. Despite the absence of neurological deficits, the extent of vertebral destruction indicated a high risk of instability and neurological compromise. Following a multidisciplinary discussion, the patient underwent posterior TES of T12 with partial rib resection, en bloc excision of the involved psoas muscle segment, artificial vertebral body replacement, and posterior instrumentation.
resultsThe surgery was completed in 250 min with 600 ml blood loss. Postoperative recovery was complicated by pulmonary atelectasis, hypoalbuminemia, and deep vein thrombosis, which were successfully managed. Pathological examination confirmed hydatid disease. At the 3-month follow-up, the patient remained neurologically intact with no signs of recurrence on imaging, demonstrating excellent short-term local control.
conclusionsThis case underscores that TES is a viable and effective option for achieving short-term local control in spinal hydatidosis, even in patients without neurological compromise, provided there is a high risk of instability. The decision for radical resection should be based on a comprehensive assessment of disease extent, patient fitness, and the potential for complete excision. However, long-term follow-up is crucial to monitor for late recurrence, and the omission of adjuvant albendazole in this case highlights a critical area for improvement in perioperative management.
Indexed as
Identifiers
42009914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.